Selected research
Industry Research
Antiallergic Non-Drug Supplements Industry Research Report 2026
Market perspective
The global Antiallergic Non-Drug Supplements market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Antiallergic Non-Drug Supplements market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Antiallergic Non-Drug Supplements market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Antiallergic Non-Drug Supplements market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Antiallergic Non-Drug Supplements include Thompson's, BY-HEALTH, Costco (Kirkland Signature), General Nutrition Center, FANCL Corporation, Blackmores, Zahler, VitaTree and Healthy Care and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Antiallergic Non-Drug Supplements market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Antiallergic Non-Drug Supplements.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Antiallergic Non-Drug Supplements Market by Company
Thompson's
BY-HEALTH
Costco (Kirkland Signature)
General Nutrition Center
FANCL Corporation
Blackmores
Zahler
VitaTree
Healthy Care
Emerald Labs
Antiallergic Non-Drug Supplements Segment by Type
Liquids
Tablets
Capsules
Antiallergic Non-Drug Supplements Segment by Application
Pollen Allergy
Dust Mites Allergy
Others
Antiallergic Non-Drug Supplements Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiallergic Non-Drug Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antiallergic Non-Drug Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiallergic Non-Drug Supplements.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Antiallergic Non-Drug Supplements companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Liquids
- Tablets
- Capsules
Applications
- Pollen Allergy
- Dust Mites Allergy
- Others
Companies covered
- Thompson's
- BY-HEALTH
- Costco (Kirkland Signature)
- General Nutrition Center
- FANCL Corporation
- Blackmores
- Zahler
- VitaTree
- Healthy Care
- Emerald Labs
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Antiallergic Non-Drug Supplements by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Liquids
- 2.2.3 Tablets
- 2.2.4 Capsules
- 2.3 Antiallergic Non-Drug Supplements by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pollen Allergy
- 2.3.3 Dust Mites Allergy
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Antiallergic Non-Drug Supplements Breakdown Data by Type
- 3.1 Global Antiallergic Non-Drug Supplements Historic Market Size by Type (2021-2026)
- 3.2 Global Antiallergic Non-Drug Supplements Forecasted Market Size by Type (2027-2032)
4 Antiallergic Non-Drug Supplements Breakdown Data by Application
- 4.1 Global Antiallergic Non-Drug Supplements Historic Market Size by Application (2021-2026)
- 4.2 Global Antiallergic Non-Drug Supplements Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Antiallergic Non-Drug Supplements Market Perspective (2021-2032)
- 5.2 Global Antiallergic Non-Drug Supplements Growth Trends by Region
- 5.2.1 Global Antiallergic Non-Drug Supplements Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Antiallergic Non-Drug Supplements Historic Market Size by Region (2021-2026)
- 5.2.3 Antiallergic Non-Drug Supplements Forecasted Market Size by Region (2027-2032)
- 5.3 Antiallergic Non-Drug Supplements Market Dynamics
- 5.3.1 Antiallergic Non-Drug Supplements Industry Trends
- 5.3.2 Antiallergic Non-Drug Supplements Market Drivers
- 5.3.3 Antiallergic Non-Drug Supplements Market Challenges
- 5.3.4 Antiallergic Non-Drug Supplements Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Antiallergic Non-Drug Supplements Players by Revenue
- 6.1.1 Global Top Antiallergic Non-Drug Supplements Players by Revenue (2021-2026)
- 6.1.2 Global Antiallergic Non-Drug Supplements Revenue Market Share by Players (2021-2026)
- 6.2 Global Antiallergic Non-Drug Supplements Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Antiallergic Non-Drug Supplements Head Office and Area Served
- 6.4 Global Antiallergic Non-Drug Supplements Players, Product Type & Application
- 6.5 Global Antiallergic Non-Drug Supplements Manufacturers Established Date
- 6.6 Global Antiallergic Non-Drug Supplements Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Antiallergic Non-Drug Supplements Market Size (2021-2032)
- 7.2 North America Antiallergic Non-Drug Supplements Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Antiallergic Non-Drug Supplements Market Size by Country (2021-2026)
- 7.4 North America Antiallergic Non-Drug Supplements Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Antiallergic Non-Drug Supplements Market Size (2021-2032)
- 8.2 Europe Antiallergic Non-Drug Supplements Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Antiallergic Non-Drug Supplements Market Size by Country (2021-2026)
- 8.4 Europe Antiallergic Non-Drug Supplements Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Antiallergic Non-Drug Supplements Market Size (2021-2032)
- 9.2 Asia-Pacific Antiallergic Non-Drug Supplements Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Antiallergic Non-Drug Supplements Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Antiallergic Non-Drug Supplements Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Antiallergic Non-Drug Supplements Market Size (2021-2032)
- 10.2 South America Antiallergic Non-Drug Supplements Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Antiallergic Non-Drug Supplements Market Size by Country (2021-2026)
- 10.4 South America Antiallergic Non-Drug Supplements Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Antiallergic Non-Drug Supplements Market Size (2021-2032)
- 11.2 Middle East & Africa Antiallergic Non-Drug Supplements Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Antiallergic Non-Drug Supplements Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Antiallergic Non-Drug Supplements Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thompson's
- 12.1.1 Thompson's Company Information
- 12.1.2 Thompson's Business Overview
- 12.1.3 Thompson's Revenue in Antiallergic Non-Drug Supplements Business (2021-2026)
- 12.1.4 Thompson's Antiallergic Non-Drug Supplements Product Portfolio
- 12.1.5 Thompson's Recent Developments
- 12.2 BY-HEALTH
- 12.2.1 BY-HEALTH Company Information
- 12.2.2 BY-HEALTH Business Overview
- 12.2.3 BY-HEALTH Revenue in Antiallergic Non-Drug Supplements Business (2021-2026)
- 12.2.4 BY-HEALTH Antiallergic Non-Drug Supplements Product Portfolio
- 12.2.5 BY-HEALTH Recent Developments
- 12.3 Costco (Kirkland Signature)
- 12.3.1 Costco (Kirkland Signature) Company Information
- 12.3.2 Costco (Kirkland Signature) Business Overview
- 12.3.3 Costco (Kirkland Signature) Revenue in Antiallergic Non-Drug Supplements Business (2021-2026)
- 12.3.4 Costco (Kirkland Signature) Antiallergic Non-Drug Supplements Product Portfolio
- 12.3.5 Costco (Kirkland Signature) Recent Developments
- 12.4 General Nutrition Center
- 12.4.1 General Nutrition Center Company Information
- 12.4.2 General Nutrition Center Business Overview
- 12.4.3 General Nutrition Center Revenue in Antiallergic Non-Drug Supplements Business (2021-2026)
- 12.4.4 General Nutrition Center Antiallergic Non-Drug Supplements Product Portfolio
- 12.4.5 General Nutrition Center Recent Developments
- 12.5 FANCL Corporation
- 12.5.1 FANCL Corporation Company Information
- 12.5.2 FANCL Corporation Business Overview
- 12.5.3 FANCL Corporation Revenue in Antiallergic Non-Drug Supplements Business (2021-2026)
- 12.5.4 FANCL Corporation Antiallergic Non-Drug Supplements Product Portfolio
- 12.5.5 FANCL Corporation Recent Developments
- 12.6 Blackmores
- 12.6.1 Blackmores Company Information
- 12.6.2 Blackmores Business Overview
- 12.6.3 Blackmores Revenue in Antiallergic Non-Drug Supplements Business (2021-2026)
- 12.6.4 Blackmores Antiallergic Non-Drug Supplements Product Portfolio
- 12.6.5 Blackmores Recent Developments
- 12.7 Zahler
- 12.7.1 Zahler Company Information
- 12.7.2 Zahler Business Overview
- 12.7.3 Zahler Revenue in Antiallergic Non-Drug Supplements Business (2021-2026)
- 12.7.4 Zahler Antiallergic Non-Drug Supplements Product Portfolio
- 12.7.5 Zahler Recent Developments
- 12.8 VitaTree
- 12.8.1 VitaTree Company Information
- 12.8.2 VitaTree Business Overview
- 12.8.3 VitaTree Revenue in Antiallergic Non-Drug Supplements Business (2021-2026)
- 12.8.4 VitaTree Antiallergic Non-Drug Supplements Product Portfolio
- 12.8.5 VitaTree Recent Developments
- 12.9 Healthy Care
- 12.9.1 Healthy Care Company Information
- 12.9.2 Healthy Care Business Overview
- 12.9.3 Healthy Care Revenue in Antiallergic Non-Drug Supplements Business (2021-2026)
- 12.9.4 Healthy Care Antiallergic Non-Drug Supplements Product Portfolio
- 12.9.5 Healthy Care Recent Developments
- 12.10 Emerald Labs
- 12.10.1 Emerald Labs Company Information
- 12.10.2 Emerald Labs Business Overview
- 12.10.3 Emerald Labs Revenue in Antiallergic Non-Drug Supplements Business (2021-2026)
- 12.10.4 Emerald Labs Antiallergic Non-Drug Supplements Product Portfolio
- 12.10.5 Emerald Labs Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst